BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 30908967)

  • 1. Structure-based design, synthesis and biological evaluation of a newer series of pyrazolo[1,5-a]pyrimidine analogues as potential anti-tubercular agents.
    Modi P; Patel S; Chhabria M
    Bioorg Chem; 2019 Jun; 87():240-251. PubMed ID: 30908967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of substituted 4,6-diarylpyrimidines and 3,5-diphenyl-4,5-dihydro-1H-pyrazoles as anti-tubercular agents.
    Pathak V; Maurya HK; Sharma S; Srivastava KK; Gupta A
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2892-6. PubMed ID: 24835631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
    Maher M; Kassab AE; Zaher AF; Mahmoud Z
    Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of some novel pyrazolo[1,5-a]pyrimidine derivatives as InhA inhibitors through pharmacophore-based virtual screening and molecular docking.
    Modi P; Patel S; Chhabria MT
    J Biomol Struct Dyn; 2019 Apr; 37(7):1736-1749. PubMed ID: 29663870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of 1H-pyrrolo[2,3-d]pyrimidine-1,2,3-triazole derivatives as novel anti-tubercular agents.
    Shiva Raju K; AnkiReddy S; Sabitha G; Siva Krishna V; Sriram D; Bharathi Reddy K; Rao Sagurthi S
    Bioorg Med Chem Lett; 2019 Jan; 29(2):284-290. PubMed ID: 30497913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrazole clubbed triazolo[1,5-a]pyrimidine hybrids as an anti-tubercular agents: Synthesis, in vitro screening and molecular docking study.
    Bhatt JD; Chudasama CJ; Patel KD
    Bioorg Med Chem; 2015 Dec; 23(24):7711-6. PubMed ID: 26631439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and evaluation of diarylpiperazine derivatives as potent anti-tubercular agents.
    Penta A; Franzblau S; Wan B; Murugesan S
    Eur J Med Chem; 2015 Nov; 105():238-44. PubMed ID: 26498570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and Structural Elucidation of Novel Benzothiazole Derivatives as Anti-tubercular Agents: In-silico Screening for Possible Target Identification.
    Venugopala KN; Chandrashekharappa S; Pillay M; Bhandary S; Kandeel M; Mahomoodally FM; Morsy MA; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K; Odhav B
    Med Chem; 2019; 15(3):311-326. PubMed ID: 29968540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis of benzocoumarin-pyrimidine hybrids as novel class of antitubercular agents, their DNA cleavage and X-ray studies.
    Reddy DS; Hosamani KM; Devarajegowda HC
    Eur J Med Chem; 2015 Aug; 101():705-15. PubMed ID: 26210508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, antimycobacterial, cytotoxicity, anti-inflammatory, in silico studies and molecular dynamics of pyrazole-embedded thiazolidin-4-one hybrids.
    Kamat V; Poojary B; Puthran D; Das VB; Kumar BK; Sankaranarayan M; Shetye G; Ma R; Franzblau SG; Nayak SP
    Arch Pharm (Weinheim); 2023 Mar; 356(3):e2200444. PubMed ID: 36461683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of carbohydrazides and carboxamides as anti-tubercular agents.
    Kumar G; Krishna VS; Sriram D; Jachak SM
    Eur J Med Chem; 2018 Aug; 156():871-884. PubMed ID: 30056283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in vitro anticancer and antitubercular activity of diarylpyrazole ligated dihydropyrimidines possessing lipophilic carbamoyl group.
    Yadlapalli RK; Chourasia OP; Vemuri K; Sritharan M; Perali RS
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2708-11. PubMed ID: 22437116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of novel quinoline-based carboxylic hydrazides as anti-tubercular agents.
    Chander S; Ashok P; Cappoen D; Cos P; Murugesan S
    Chem Biol Drug Des; 2016 Oct; 88(4):585-91. PubMed ID: 27203404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4,5-Dihydro-1H-pyrazolo[3,4-d]pyrimidine containing phenothiazines as antitubercular agents.
    Siddiqui AB; Trivedi AR; Kataria VB; Shah VH
    Bioorg Med Chem Lett; 2014 Mar; 24(6):1493-5. PubMed ID: 24582983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Click synthesis of 1,2,3-triazole based imidazoles: Antitubercular evaluation, molecular docking and HSA binding studies.
    Pradeep Kumar CB; Prathibha BS; Prasad KNN; Raghu MS; Prashanth MK; Jayanna BK; Alharthi FA; Chandrasekhar S; Revanasiddappa HD; Yogesh Kumar K
    Bioorg Med Chem Lett; 2021 Mar; 36():127810. PubMed ID: 33482292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, molecular docking and anti-mycobacterial evaluation of new imidazo[1,2-a]pyridine-2-carboxamide derivatives.
    Jose G; Suresha Kumara TH; Nagendrappa G; Sowmya HB; Sriram D; Yogeeswari P; Sridevi JP; Guru Row TN; Hosamani AA; Sujan Ganapathy PS; Chandrika N; Narendra LV
    Eur J Med Chem; 2015 Jan; 89():616-27. PubMed ID: 25462270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and pharmacological evaluation of fluorinated azoles as anti-tubercular agents.
    Gholap S; Tambe M; Nawale L; Sarkar D; Sangshetti J; Damale M
    Arch Pharm (Weinheim); 2018 Feb; 351(2):. PubMed ID: 29292534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-Pot Synthesis of Novel Hydrazono-1,3-Thıazolıdın-4-One Derivatives as Anti-HIV and Anti-Tubercular Agents: Synthesıs, Bıologıcal Evaluatıon, Molecular Modelling and Admet Studıes.
    Pasha MA; Mondal S; Panigrahi N; Shetye G; Ma R; Franzblau SG; Zheng YT; Murugesan S
    Curr HIV Res; 2022; 20(3):255-271. PubMed ID: 35549861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of newer pyrazole derivatives with potential anti-tubercular activity via 3D-QSAR based pharmacophore modelling, virtual screening, molecular docking and molecular dynamics simulation studies.
    Modi P; Patel S; Chhabria M
    Mol Divers; 2023 Aug; 27(4):1547-1566. PubMed ID: 35969333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.